Literature DB >> 31136288

Determinants of Early Versus Delayed Neurological Deterioration in Intracerebral Hemorrhage.

Shoujiang You1, Danni Zheng2,3, Candice Delcourt3,4, Shoichiro Sato5, Yongjun Cao1, Shihong Zhang6, Jie Yang7, Xia Wang3, Richard I Lindley8, Thompson Robinson9, Craig S Anderson3,4,10, John Chalmers3.   

Abstract

Background and Purpose- We investigated factors associated with early and delayed neurological deterioration (END and DND, respectively) after acute spontaneous intracerebral hemorrhage in the main INTERACT (Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial)-2. Methods- INTERACT-2 was a randomized trial of early intensive versus guideline-recommended blood pressure lowering in hypertensive intracerebral hemorrhage (<6 hours from symptom onset) patients. END and DND were defined as a ≥4-point increase on the National Institutes of Health Stroke Scale or ≥2-point decrease on Glasgow Coma Scale, in periods baseline to 24 hours and 24 hours to 7 days, respectively. Multivariable logistic regression models were used to determine independent predictors of END and DND and 90-day outcomes (death and dependency on the modified Rankin Scale). Results- Of 2598 participants, 450 (17.3%) had either END or DND. Non-China recruitment, higher systolic blood pressure, larger baseline hematoma volume, left hemisphere hematoma location, intraventricular hemorrhage, subarachnoid extension, heterogeneous hematoma density, and cerebral white matter lesions, were predictors of END (all P≤0.045). Higher systolic blood pressure, lower diastolic blood pressure, higher glucose, larger baseline hematoma volume, intraventricular hemorrhage, lobar location, brain atrophy, and heterogeneous hematoma density were predictors of DND (all P≤0.042). END and DND were both related to death, and death or major disability (modified Rankin Scale scores of 3-6), in adjusted analyses ( P<0.001). Conclusions- Common variables, most directly related to the intracerebral hemorrhage morphology and underlying cerebral features, determine END and DND and their influence on poor outcomes of death and major disability. Clinical Trial Registration- URL: https://www.clinicaltrials.gov . Unique identifier: NCT00716079.

Entities:  

Keywords:  atrophy; blood pressure; cerebral hemorrhage; hematoma; white matter

Year:  2019        PMID: 31136288     DOI: 10.1161/STROKEAHA.118.024403

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  13 in total

1.  High plasma levels of trimethylamine N-oxide are associated with poor outcome in intracerebral hemorrhage patients.

Authors:  Qijin Zhai; Taipeng Sun; Chuanfu Sun; Luxia Yan; Xiang Wang; Yuqian Wang; Junshan Sun; Ying Zhao
Journal:  Neurol Sci       Date:  2020-07-23       Impact factor: 3.307

2.  A Prediction Model for Neurological Deterioration in Patients with Acute Spontaneous Intracerebral Hemorrhage.

Authors:  Daiquan Gao; Xiaojuan Zhang; Yunzhou Zhang; Rujiang Zhang; Yuanyuan Qiao
Journal:  Front Surg       Date:  2022-05-27

3.  Intracerebral Hemorrhage Progression Score: A Novel Risk Score to Predict Neurological Deterioration after Intracerebral Hemorrhage.

Authors:  Ruijun Ji; Linlin Wang; Feifei Ma; Wenjuan Wang; Yanfang Liu; Runhua Zhang; Dandan Wang; Jiaokun Jia; Hao Feng; Gaifen Liu; Yi Ju; Jingjing Lu; Xingquan Zhao
Journal:  J Stroke       Date:  2022-05-31       Impact factor: 8.632

4.  Frequency, Risk Factors, and Outcomes of Unplanned Readmission to the Neurological Intensive Care Unit after Spontaneous Intracerebral Hemorrhage.

Authors:  Ruth Tangonan; Ronald Alvarado-Dyer; Andrea Loggini; Faten El Ammar; Ruchit Kumbhani; Christos Lazaridis; Christopher Kramer; Fernando D Goldenberg; Ali Mansour
Journal:  Neurocrit Care       Date:  2022-01-24       Impact factor: 3.532

5.  Targeted Delivery of Iron Oxide Nanoparticle-Loaded Human Embryonic Stem Cell-Derived Spherical Neural Masses for Treating Intracerebral Hemorrhage.

Authors:  Min Kyoung Kang; Tae Jung Kim; Young-Ju Kim; Lamie Kang; Jonghoon Kim; Nohyun Lee; Taeghwan Hyeon; Mi-Sun Lim; Hee Jung Mo; Jung Hwan Shin; Sang-Bae Ko; Byung-Woo Yoon
Journal:  Int J Mol Sci       Date:  2020-05-22       Impact factor: 5.923

6.  Predictors and Outcomes of Neurological Deterioration in Intracerebral Hemorrhage: Results from the TICH-2 Randomized Controlled Trial.

Authors:  Zhe Kang Law; Rob Dineen; Timothy J England; Lesley Cala; Amit K Mistri; Jason P Appleton; Serefnur Ozturk; Daniel Bereczki; Alfonso Ciccone; Philip M Bath; Nikola Sprigg
Journal:  Transl Stroke Res       Date:  2020-09-09       Impact factor: 6.829

Review 7.  Prognostication after intracerebral hemorrhage: a review.

Authors:  Jens Witsch; Bob Siegerink; Christian H Nolte; Maximilian Sprügel; Thorsten Steiner; Matthias Endres; Hagen B Huttner
Journal:  Neurol Res Pract       Date:  2021-05-03

8.  A new surgical method of treatment spontaneous intracranial hemorrhage.

Authors:  Ning Du; Xinjun Wang; Xuyang Zhang; Jingwei Xie; Shaolong Zhou; Yuehui Wu; Yongkun Guo
Journal:  Transl Neurosci       Date:  2021-04-20       Impact factor: 1.757

9.  Memantine protects blood-brain barrier integrity and attenuates neurological deficits through inhibiting nitric oxide synthase ser1412 phosphorylation in intracerebral hemorrhage rats: involvement of peroxynitrite-related matrix metalloproteinase-9/NLRP3 inflammasome activation.

Authors:  Xiaowei Chen; Xu Xiang; Teng Xie; Zhijun Chen; Yu Mou; Zixu Gao; Xun Xie; Min Song; Hui Huang; Ziyun Gao; Min Chen
Journal:  Neuroreport       Date:  2021-02-03       Impact factor: 1.703

10.  Intracerebral Hemorrhage with Intraventricular Extension Associated with Loss of Consciousness at Symptom Onset.

Authors:  Jens Witsch; Guido J Falcone; Audrey C Leasure; Charles Matouk; Matthias Endres; Lauren Sansing; Daniel Woo; Kevin N Sheth
Journal:  Neurocrit Care       Date:  2021-01-21       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.